A Randomized Observer-blinded Controlled Non-inferiority Trial to Evaluate the Immunogenicity of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladeshi Healthy Adults.
Phase of Trial: Phase II/III
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal infections
- Focus Pharmacodynamics
- 21 Mar 2018 Status changed from not yet recruiting to completed.
- 25 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Sep 2017.
- 31 Aug 2017 New trial record